Development and characterization of cores-shell poly(lactide-co-glycolide)-chitosan microparticles for sustained release of GDNF.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Colloids and Surfaces B: Biointerfaces

• Publication date

  2017-11-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.colsurfb.2017.08.052PMID 28886515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noncovalent Bonding of RGD and YIGSR to an Electrospun Poly(ε‐Caprolactone) Conduit through Peptide Self‐Assembly to Synergistically Promote Sciatic Nerve Regeneration in Rats

  2017cited by this paper
• Characterization and biocompatibility of injectable microspheres-loaded hydrogel for methotrexate delivery.

  2016cited by this paper
• Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanism.

  2016cited by this paper
• A glial cell line-derived neurotrophic factor delivery system enhances nerve regeneration across acellular nerve allografts.

  2016cited by this paper
• PLGA/alginate composite microspheres for hydrophilic protein delivery.

  2015cited by this paper
• Fabrication of chitosan microspheres using vanillin/TPP dual crosslinkers for protein antigens encapsulation.

  2015cited by this paper
• Incorporation of Chitosan Microspheres into Collagen-Chitosan Scaffolds for the Controlled Release of Nerve Growth Factor

  2014cited by this paper
• Controlled protein release from monodisperse biodegradable double-wall microspheres of controllable shell thickness.

  2013cited by this paper
• Cross-linked chitosan microspheres for oral delivery of insulin: Taguchi design and in vivo testing.

  2012cited by this paper
• Ionically cross-linked chitosan microspheres for controlled release of bioactive nerve growth factor.

  2011cited by this paper
• A spheres-in-sphere structure for improving protein-loading poly (lactide-co-glycolide) microspheres

  2010cited by this paper
• Controlled delivery of paracetamol and protein at different stages from core–shell biodegradable microspheres

  2010cited by this paper
• Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.

  2009cited by this paper
• Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2.

  2009cited by this paper
• Preparation and characterization of chitosan microspheres for controlled release of synthetic oligopeptide derived from BMP-2

  2009cited by this paper
• Three-step experimental design to determine the effect of process parameters on the size of chitosan microspheres

  2009cited by this paper
• In vitro degradation and release behavior of porous poly(lactic acid) scaffolds containing chitosan microspheres as a carrier for BMP-2-derived synthetic peptide

  2009cited by this paper
• Effect of chitooligosaccharide on neuronal differentiation of PC‐12 cells

  2009cited by this paper
• Neuroregenerative effects of lentiviral vector-mediated GDNF expression in reimplanted ventral roots.

  2008cited by this paper
• Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.

  2008cited by this paper
• Neural plasticity after peripheral nerve injury and regeneration.

  2007cited by this paper
• Properties and degradation of selected polysaccharides: Hyaluronan and chitosan

  2007cited by this paper
• Peripheral regeneration.

  2007cited by this paper
• Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor.

  2007cited by this paper
• One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands.

  2006cited by this paper
• In vitro study of GDNF release from biodegradable PLGA microspheres.

  2004cited by this paper
• Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor.

  2004cited by this paper
• Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer.

  2002cited by this paper
• Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: Biodegradation

  2001cited by this paper
• Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review.

  2000cited by this paper
• Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release.

  1999cited by this paper
• Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis

  1998cited by this paper
• Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence.

  1995cited by this paper
• MORE ABOUT THE DEGRADATION OF LA/GA – DERIVED MATRICES IN AQUEOUS MEDIA

  1991cited by this paper

• Curcumin encapsulated PLGA-chitosan nanocarrier: Fabrication, characterization, and in vitro differentiation evaluation on PC12 cells

  2026cites this paper
• Synergistic aligned neuronal and vascular growth inside 3D-PEG-Anisogels utilizing a triple-co-culture

  2025cites this paper
• Advancements in Protein-Based Therapeutic Delivery Approaches Targeting the Blood-Brain Barrier and Insights on Computational Strategies.

  2025cites this paper
• Cutting-edge progress in the protective efficacy of nanovaccines against poultry diseases

  2025cites this paper
• Enzyme and pH dual-responsive CAP@CS@PLGA microcapsules for controlled release antibacterial application

  2023cites this paper
• Chitosan-Based Particulate Carriers: Structure, Production and Corresponding Controlled Release

  2023cites this paper
• Recent Advances in Polymeric Drug Delivery Systems for Peripheral Nerve Regeneration

  2023cites this paper
• Gentiopicroside PLGA Nanospheres: Fabrication, in vitro Characterization, Antimicrobial Action, and in vivo Effect for Enhancing Wound Healing in Diabetic Rats

  2022cites this paper
• Microsphere-containing hydrogel scaffolds  for tissue engineering.

  2022cites this paper
• Natural Polymer‐Derived Bioscaffolds for Peripheral Nerve Regeneration

  2022cites this paper
• Functional microspheres for tissue regeneration.

  2022cites this paper
• Sustain release of loaded insulin within biomimetic hydrogel microsphere for sciatic tissue engineering in vivo.

  2022cites this paper
• PLGA Core-Shell Nano/Microparticle Delivery System for Biomedical Application

  2021cites this paper
• TPP ionically cross-linked chitosan/PLGA microspheres for the delivery of NGF for peripheral nerve system repair.

  2021cites this paper
• [The fabrication and related properties study of chitosan-poly (lactide-co-glycolide) double-walled microspheres loaded with nerve growth factor].

  2020cites this paper
• Design and applications of protein delivery systems in nanomedicine and tissue engineering.

  2020cites this paper
• Au nanoparticles coated with chitosan

  2019cites this paper
• Application of stem cells and chitosan in the repair of spinal cord injury

  2019cites this paper
• Nanomaterial-Based Approaches for Neural Regeneration

  2019cites this paper
• Porous aerogel and core/shell nanoparticles for controlled drug delivery: A review.

  2019cites this paper
• Electrospun Acid-neutralizing Fibers for the Amelioration of Inflammatory Response.

  2019cites this paper
• Approaches to Improve Therapeutic Efficacy of Biodegradable PLA/PLGA Microspheres: A Review

  2018cites this paper
• Current Status of Nonviral Vectors for Gene Therapy in China

  2018cites this paper